SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-21-000033
Filing Date
2021-01-12
Accepted
2021-01-12 07:02:02
Documents
3
Period of Report
2021-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inspyrtherapeutics_8-k.htm 8-K 39881
2 EXHIBIT 10.01 inspyrtherapeutics_ex10-01.htm EX-10.01 163786
3 EXHIBIT 99.01 inspyrtherapeutics_ex99-01.htm EX-99.01 12888
  Complete submission text file 0001829126-21-000033.txt   217991
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 21522399
SIC: 2834 Pharmaceutical Preparations